New Orders Set To Clear Indian Trial Bottlenecks ‘Soon’
This article was originally published in PharmAsia News
Executive Summary
India's drugs regulator has indicated that bottlenecks impeding the flow of clinical trial-related activity in the country will be done away with, and that orders pertaining to a host of contentious clauses are likely soon.